Cargando…

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Glintborg, Dorte, Rubin, Katrine Hass, Nybo, Mads, Abrahamsen, Bo, Andersen, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844097/
https://www.ncbi.nlm.nih.gov/pubmed/29519249
http://dx.doi.org/10.1186/s12933-018-0680-5
_version_ 1783305196672122880
author Glintborg, Dorte
Rubin, Katrine Hass
Nybo, Mads
Abrahamsen, Bo
Andersen, Marianne
author_facet Glintborg, Dorte
Rubin, Katrine Hass
Nybo, Mads
Abrahamsen, Bo
Andersen, Marianne
author_sort Glintborg, Dorte
collection PubMed
description BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemia. PCOS Denmark (N = 18,112) included women with PCOS in the Danish National Patient Register. PCOS Odense University Hospital (OUH, N = 1165) was an embedded cohort including premenopausal women with PCOS and clinical and biochemical examination. Three age-matched controls were included per patient in PCOS Denmark (N = 52,769). The main study outcome was CVD events including hypertension and dyslipidemia defined according to nationwide in- and outpatient hospital contact diagnosis codes and/or inferred from filled medicine prescriptions. RESULTS: The age at inclusion was median (quartiles) 29 (23–35) years and follow up was 11.1 (6.9–16.0) years. The Hazard ratio (95% CI) for development of CVD in PCOS Denmark was 1.7 (1.7; 1.8) (P < 0.001) and the total event rate of CVD was 22.6 per 1000 patient years in PCOS Denmark vs. 13.2 per 1000 patient years in controls (P < 0.001). The median age at diagnosis of CVD was 35 (28–42) years in PCOS Denmark vs. 36 (30–43) years in controls (P < 0.001). Obesity, diabetes, and infertility, and previous use of oral contraceptives were associated with increased risk of development of CVD in PCOS Denmark (P < 0.001). Women in PCOS OUH resembled women in PCOS Denmark regarding risk of CVD. Age, BMI, blood pressure, lipid status, and glycemic status predicted development of CVD in PCOS OUH. CONCLUSION: The event rate of CVD including hypertension and dyslipidemia was higher in PCOS compared to controls. The risk of developing CVD must be considered even in young women with PCOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12933-018-0680-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5844097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58440972018-03-14 Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome Glintborg, Dorte Rubin, Katrine Hass Nybo, Mads Abrahamsen, Bo Andersen, Marianne Cardiovasc Diabetol Original Investigation BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and low grade inflammation and the risk for cardiovascular disease (CVD) could be increased in PCOS. METHODS: National register-based study including women with PCOS and no previous diagnosis of CVD, hypertension, or dyslipidemia. PCOS Denmark (N = 18,112) included women with PCOS in the Danish National Patient Register. PCOS Odense University Hospital (OUH, N = 1165) was an embedded cohort including premenopausal women with PCOS and clinical and biochemical examination. Three age-matched controls were included per patient in PCOS Denmark (N = 52,769). The main study outcome was CVD events including hypertension and dyslipidemia defined according to nationwide in- and outpatient hospital contact diagnosis codes and/or inferred from filled medicine prescriptions. RESULTS: The age at inclusion was median (quartiles) 29 (23–35) years and follow up was 11.1 (6.9–16.0) years. The Hazard ratio (95% CI) for development of CVD in PCOS Denmark was 1.7 (1.7; 1.8) (P < 0.001) and the total event rate of CVD was 22.6 per 1000 patient years in PCOS Denmark vs. 13.2 per 1000 patient years in controls (P < 0.001). The median age at diagnosis of CVD was 35 (28–42) years in PCOS Denmark vs. 36 (30–43) years in controls (P < 0.001). Obesity, diabetes, and infertility, and previous use of oral contraceptives were associated with increased risk of development of CVD in PCOS Denmark (P < 0.001). Women in PCOS OUH resembled women in PCOS Denmark regarding risk of CVD. Age, BMI, blood pressure, lipid status, and glycemic status predicted development of CVD in PCOS OUH. CONCLUSION: The event rate of CVD including hypertension and dyslipidemia was higher in PCOS compared to controls. The risk of developing CVD must be considered even in young women with PCOS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12933-018-0680-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-08 /pmc/articles/PMC5844097/ /pubmed/29519249 http://dx.doi.org/10.1186/s12933-018-0680-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Glintborg, Dorte
Rubin, Katrine Hass
Nybo, Mads
Abrahamsen, Bo
Andersen, Marianne
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title_full Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title_fullStr Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title_full_unstemmed Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title_short Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
title_sort cardiovascular disease in a nationwide population of danish women with polycystic ovary syndrome
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844097/
https://www.ncbi.nlm.nih.gov/pubmed/29519249
http://dx.doi.org/10.1186/s12933-018-0680-5
work_keys_str_mv AT glintborgdorte cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome
AT rubinkatrinehass cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome
AT nybomads cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome
AT abrahamsenbo cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome
AT andersenmarianne cardiovasculardiseaseinanationwidepopulationofdanishwomenwithpolycysticovarysyndrome